Press
·
News
POELLATH advises NEOsphere Biotechnologies GmbH on Series A financing round of EUR 6 million
NEOsphere is a biotech start-up based in Planegg near Munich, Germany, that has developed a specialized data analytics platform for the pharmaceutical field, opening up numerous new avenues in drug discovery.
Ventura Biomed Investors is a biotech VC investor whose focus is on early-stage life science companies developing breakthrough technologies and innovative therapies.
POELLATH advised NEOsphere on the financing round with the following Munich team:
- Christian Toenies (partner, M&A/VC)
- Dr. Sebastian Gerlinger (counsel, lead, M&A/VC)
- Markus Döllner (senior associate, M&A/VC)
Contact
